Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cholerton

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Clinical Pharmacology|October 1, 1998
Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6H Hadidi, Y Irshaid, C B Vågbø, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The N-oxidation of trimethylamine in a Jordanian populationH F Hadidi, S Cholerton, S Atkinson, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patientsI A Choonara, A K Scott, B P Haynes, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluidS C Monkman, J S Ellis, S Cholerton, et al.
The Quarterly Journal of Medicine|January 1, 1986
Problems of anticoagulation with warfarin in hyperthyroidismH A Kellett, J S Sawers, F E Boulton, et al.
Chirality|January 1, 1991
Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteersR Ayesh, S Dawling, A Hayler, et al.
Journal of the Royal Society of Medicine|March 1, 1990
Acute changes in atherogenic and thrombogenic factors with cessation of smokingM D Feher, M W Rampling, J Brown, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
The effect of fluconazole on cyclophosphamide metabolism in childrenS M Yule, D Walker, M Cole, et al.
Lancet (London, England)|January 1, 1994
Poor metabolisers of nicotine and CYP2D6 polymorphismS Cholerton, A Arpanahi, N McCracken, et al.
British Journal of Cancer|April 14, 2005
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancerI Willits, L Price, A Parry, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|October 1, 1998
Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6H Hadidi, Y Irshaid, C B Vågbø, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The N-oxidation of trimethylamine in a Jordanian populationH F Hadidi, S Cholerton, S Atkinson, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patientsI A Choonara, A K Scott, B P Haynes, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluidS C Monkman, J S Ellis, S Cholerton, et al.
The Quarterly Journal of Medicine|January 1, 1986
Problems of anticoagulation with warfarin in hyperthyroidismH A Kellett, J S Sawers, F E Boulton, et al.
Chirality|January 1, 1991
Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteersR Ayesh, S Dawling, A Hayler, et al.
Journal of the Royal Society of Medicine|March 1, 1990
Acute changes in atherogenic and thrombogenic factors with cessation of smokingM D Feher, M W Rampling, J Brown, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
The effect of fluconazole on cyclophosphamide metabolism in childrenS M Yule, D Walker, M Cole, et al.
Lancet (London, England)|January 1, 1994
Poor metabolisers of nicotine and CYP2D6 polymorphismS Cholerton, A Arpanahi, N McCracken, et al.
British Journal of Cancer|April 14, 2005
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancerI Willits, L Price, A Parry, et al.
Pageof 4